1. Home
  2. RNXT vs CXAI Comparison

RNXT vs CXAI Comparison

Compare RNXT & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • CXAI
  • Stock Information
  • Founded
  • RNXT 2012
  • CXAI N/A
  • Country
  • RNXT United States
  • CXAI United States
  • Employees
  • RNXT N/A
  • CXAI N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • CXAI EDP Services
  • Sector
  • RNXT Health Care
  • CXAI Technology
  • Exchange
  • RNXT Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • RNXT 31.6M
  • CXAI 33.9M
  • IPO Year
  • RNXT 2021
  • CXAI N/A
  • Fundamental
  • Price
  • RNXT $1.03
  • CXAI $1.50
  • Analyst Decision
  • RNXT Strong Buy
  • CXAI
  • Analyst Count
  • RNXT 1
  • CXAI 0
  • Target Price
  • RNXT $9.00
  • CXAI N/A
  • AVG Volume (30 Days)
  • RNXT 214.8K
  • CXAI 608.9K
  • Earning Date
  • RNXT 03-31-2025
  • CXAI 04-14-2025
  • Dividend Yield
  • RNXT N/A
  • CXAI N/A
  • EPS Growth
  • RNXT N/A
  • CXAI N/A
  • EPS
  • RNXT N/A
  • CXAI N/A
  • Revenue
  • RNXT N/A
  • CXAI $7,200,000.00
  • Revenue This Year
  • RNXT N/A
  • CXAI $3.86
  • Revenue Next Year
  • RNXT N/A
  • CXAI $100.00
  • P/E Ratio
  • RNXT N/A
  • CXAI N/A
  • Revenue Growth
  • RNXT N/A
  • CXAI N/A
  • 52 Week Low
  • RNXT $0.77
  • CXAI $1.09
  • 52 Week High
  • RNXT $1.86
  • CXAI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 35.37
  • CXAI 41.74
  • Support Level
  • RNXT $1.00
  • CXAI $1.46
  • Resistance Level
  • RNXT $1.18
  • CXAI $1.69
  • Average True Range (ATR)
  • RNXT 0.10
  • CXAI 0.10
  • MACD
  • RNXT -0.03
  • CXAI 0.01
  • Stochastic Oscillator
  • RNXT 6.00
  • CXAI 30.19

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

Share on Social Networks: